Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
This report contains market size and forecasts of Large Volume Wearable Injectors in global, including the following market information:
Global Large Volume Wearable Injectors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Large Volume Wearable Injectors Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Large Volume Wearable Injectors companies in 2021 (%)
The global Large Volume Wearable Injectors market was valued at 1513.6 million in 2021 and is projected to reach US$ 10550 million by 2028, at a CAGR of 32.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Electronical Injectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Large Volume Wearable Injectors include West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical AG, BD Medical, Enable Injections, Roche Laboratories, scPharmaceuticals and SteadyMed Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Large Volume Wearable Injectors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Large Volume Wearable Injectors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Large Volume Wearable Injectors Market Segment Percentages, by Type, 2021 (%)
Electronical Injectors
Mechanical Injectors
Others
Global Large Volume Wearable Injectors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Large Volume Wearable Injectors Market Segment Percentages, by Application, 2021 (%)
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
Global Large Volume Wearable Injectors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Large Volume Wearable Injectors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Large Volume Wearable Injectors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Large Volume Wearable Injectors revenues share in global market, 2021 (%)
Key companies Large Volume Wearable Injectors sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Large Volume Wearable Injectors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson